These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8472027)

  • 1. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G; Zalutsky MR
    Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No-carrier-added meta-[123I]iodobenzylguanidine: synthesis and preliminary evaluation.
    Vaidyanathan G; Zalutsky MR
    Nucl Med Biol; 1995 Jan; 22(1):61-4. PubMed ID: 7735171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    J Med Chem; 1994 Oct; 37(21):3655-62. PubMed ID: 7932592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
    J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
    Vaidyanathan G; McDougald D; Koumarianou E; Choi J; Hens M; Zalutsky MR
    Nucl Med Biol; 2015 Aug; 42(8):673-84. PubMed ID: 25956997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.
    Vaidyanathan G; Friedman HS; Keir ST; Zalutsky MR
    Br J Cancer; 1996 May; 73(10):1171-7. PubMed ID: 8630274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation.
    Vaidyanathan G; Zalutsky MR
    Bioconjug Chem; 1992; 3(6):499-503. PubMed ID: 1463779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
    Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
    J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
    Mairs RJ; Russell J; Cunningham S; O'Donoghue JA; Gaze MN; Owens J; Vaidyanathan G; Zalutsky MR
    Eur J Cancer; 1995; 31A(4):576-81. PubMed ID: 7576972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Bioconjug Chem; 1996; 7(1):102-7. PubMed ID: 8741997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
    Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
    Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
    Strickland DK; Vaidyanathan G; Friedman HS; Zalutsky MR
    J Neurooncol; 1995; 25(1):9-17. PubMed ID: 8523094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
    Vaidyanathan G; Welsh PC; Vitorello KC; Snyder S; Friedman HS; Zalutsky MR
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1362-70. PubMed ID: 15205923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
    Gaze MN; Hamilton TG; Mairs RJ
    Br J Radiol; 1994 Jun; 67(798):573-8. PubMed ID: 8032811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine.
    Mairs RJ; Gaze MN; Watson DG; Skellern GG; Constable P; McKellar K; Owens J; Vaidyanathan G; Zalutsky MR
    Nucl Med Commun; 1994 Apr; 15(4):268-74. PubMed ID: 8072739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
    Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
    Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
    Armour A; Mairs RJ; Gaze MN; Wheldon TE
    Br J Cancer; 1994 Sep; 70(3):445-8. PubMed ID: 8080728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
    Rutgers M; Tytgat GA; Verwijs-Janssen M; Buitenhuis C; Voûte PA; Smets LA
    Int J Cancer; 1993 May; 54(2):290-5. PubMed ID: 8486431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.